Dr Jogin Desai

Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisors

Bengaluru, February 23, 2023: Eyestem, a Bengaluru-based Cell Therapy company, with a focus on Ophthalmology, has appointed Ravi Achar as Head- North America…

2 years ago

Views of Dr Jogin Desai, Co-founder & CEO, Eyestem on Union Finance Budget 2023–2024

New Delhi, February 01, 2023: The mission mode programme to eradicate sickle cell anemia can be tremendously impactful.  Such programmes…

2 years ago